- Home
- TYL vs DGX Comparison
TYL vs DGX Comparison
Compare TYL & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYL
- DGX
- Stock Information
- Founded
- TYL 1966
- DGX 1967
- Country
- TYL United States
- DGX United States
- Employees
- TYL N/A
- DGX N/A
- Industry
- TYL Computer Software: Prepackaged Software
- DGX Medical Specialities
- Sector
- TYL Technology
- DGX Health Care
- Exchange
- TYL Nasdaq
- DGX Nasdaq
- Market Cap
- TYL 22.4B
- DGX 20.5B
- IPO Year
- TYL N/A
- DGX 1996
- Fundamental
- Price
- TYL $469.30
- DGX $187.42
- Analyst Decision
- TYL Buy
- DGX Buy
- Analyst Count
- TYL 9
- DGX 15
- Target Price
- TYL $666.78
- DGX $194.07
- AVG Volume (30 Days)
- TYL 372.1K
- DGX 1.2M
- Earning Date
- TYL 10-29-2025
- DGX 10-21-2025
- Dividend Yield
- TYL N/A
- DGX 1.71%
- EPS Growth
- TYL 31.32
- DGX 14.49
- EPS
- TYL 7.19
- DGX 8.51
- Revenue
- TYL $2,298,292,000.00
- DGX $10,850,000,000.00
- Revenue This Year
- TYL $10.91
- DGX $12.37
- Revenue Next Year
- TYL $9.03
- DGX $3.51
- P/E Ratio
- TYL $64.85
- DGX $22.03
- Revenue Growth
- TYL 10.62
- DGX 13.74
- 52 Week Low
- TYL $450.00
- DGX $148.70
- 52 Week High
- TYL $661.31
- DGX $197.55
- Technical
- Relative Strength Index (RSI)
- TYL 37.27
- DGX 59.85
- Support Level
- TYL $456.00
- DGX $184.50
- Resistance Level
- TYL $474.00
- DGX $190.47
- Average True Range (ATR)
- TYL 15.17
- DGX 4.20
- MACD
- TYL 0.31
- DGX 1.16
- Stochastic Oscillator
- TYL 30.55
- DGX 77.88
About TYL Tyler Technologies Inc.
Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.